J W Voss

1.7k total citations · 2 hit papers
10 papers, 1.3k citations indexed

About

J W Voss is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Rheumatology. According to data from OpenAlex, J W Voss has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in J W Voss's work include Growth Hormone and Insulin-like Growth Factors (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Pluripotent Stem Cells Research (2 papers). J W Voss is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Pluripotent Stem Cells Research (2 papers). J W Voss collaborates with scholars based in United States, France and Germany. J W Voss's co-authors include Michael G. Rosenfeld, Donna M. Simmons, Jeffrey M. Holloway, Holly A. Ingraham, Ron S. Broide, Larry W. Swanson, L Wilson, Robert J. Padley, Jonathan S. George and Matthew Rosebraugh and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

J W Voss

10 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors.

1990 527 citations Donna M. Simmons, J W Voss et al. Genes & Development profile →
In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

2018 276 citations Julie Parmentier, J W Voss et al. BMC Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J W Voss United States	8	585	575	385	197	146	10	1.3k
Pavel N. Pichurin United States	23	918 1.6×	429 0.7×	652 1.7×	61 0.3×	593 4.1×	62	1.8k
Adam Denley Australia	12	732 1.3×	1.1k 1.9×	237 0.6×	33 0.2×	74 0.5×	15	1.6k
G. Levan Sweden	25	141 0.2×	1.1k 1.9×	588 1.5×	50 0.3×	203 1.4×	99	1.8k
Christina Chaivorapol United States	8	130 0.2×	503 0.9×	243 0.6×	196 1.0×	288 2.0×	11	1.0k
Jakub Abramson Israel	23	568 1.0×	563 1.0×	285 0.7×	77 0.4×	1.4k 9.8×	38	2.2k
Consuelo González‐Manchón Spain	18	290 0.5×	536 0.9×	165 0.4×	29 0.1×	87 0.6×	61	1.2k
Frances Benham United Kingdom	17	171 0.3×	648 1.1×	370 1.0×	54 0.3×	57 0.4×	35	1.1k
Philip G. Hollingshead United States	13	481 0.8×	964 1.7×	426 1.1×	24 0.1×	115 0.8×	16	1.9k
Jerzy Trojan France	17	325 0.6×	586 1.0×	224 0.6×	20 0.1×	219 1.5×	62	1.1k
Gabriella Wright United States	8	733 1.3×	463 0.8×	172 0.4×	37 0.2×	52 0.4×	9	1000

Countries citing papers authored by J W Voss

Since Specialization

Citations

This map shows the geographic impact of J W Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J W Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J W Voss more than expected).

Fields of papers citing papers by J W Voss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J W Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J W Voss. The network helps show where J W Voss may publish in the future.

Co-authorship network of co-authors of J W Voss

This figure shows the co-authorship network connecting the top 25 collaborators of J W Voss. A scholar is included among the top collaborators of J W Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J W Voss. J W Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Parmentier, Julie, J W Voss, Candace Graff, et al.. (2018). In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatology. 2(1). 23–23. 276 indexed citations breakdown →

2.

Tripp, Catherine S., Carolyn A. Cuff, Andrew Campbell, et al.. (2017). RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study. Advances in Therapy. 34(6). 1364–1381. 30 indexed citations

3.

Bryant, Shaughn H., et al.. (2014). THU0521 Dual Neutralization of TNF and IL-17 with A Dvd-Ig Protein is Efficacious in Collagen Induced Arthritis. Annals of the Rheumatic Diseases. 73. 363–363. 4 indexed citations

4.

Stuhlmüller, Bruno, Thomas Häupl, Andreas Grützkau, et al.. (2009). CD11c as a Transcriptional Biomarker to Predict Response to Anti-TNF Monotherapy With Adalimumab in Patients With Rheumatoid Arthritis. Clinical Pharmacology & Therapeutics. 87(3). 311–321. 62 indexed citations

5.

Kamens, Joanne, et al.. (2004). cis-Element clustering correlates with dose-dependent pro- and antisignaling effects of IL18. Genes and Immunity. 5(5). 354–362. 5 indexed citations

6.

Voss, J W, L Wilson, Simon J. Rhodes, & Michael G. Rosenfeld. (1993). An alternative Pit-1 RNA splicing product reveals modular binding and nonmodular transcriptional activities of the POU-specific domain.. Molecular Endocrinology. 7(12). 1551–1560. 27 indexed citations

7.

Voss, J W. (1992). Anterior pituitary development: Short tales from dwarf mice. Cell. 70(4). 527–530. 174 indexed citations

8.

Voss, J W, Tianliang Yao, & M G Rosenfeld. (1991). Alternative translation initiation site usage results in two structurally distinct forms of Pit-1. Journal of Biological Chemistry. 266(20). 12832–12835. 50 indexed citations

9.

Voss, J W, L Wilson, & Michael G. Rosenfeld. (1991). POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter.. Genes & Development. 5(7). 1309–1320. 182 indexed citations

10.

Simmons, Donna M., J W Voss, Holly A. Ingraham, et al.. (1990). Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors.. Genes & Development. 4(5). 695–711. 527 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact